In the group receiving 100 mg vildagliptin daily and continuing metformin treatment, more than three-quarters of patients experienced a meaningful (41.3%) or marked (37.1%) improvement in glycemic ...

Vildagliptin is a medicine used to treat type ... In the United Kingdom it is listed as less preferred than metformin or a sulfonylurea. It is taken by mouth. It is also available in the fixed ...

Objective: We sought to evaluate the efficacy and safety of vildagliptin, a new dipeptidyl peptidase-4 inhibitor, added to metformin during 24 weeks of treatment in patients with type 2 diabetes.